coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Warrington Innovation PCN, Warrington (LAD) · Health Inequalities Profile

    PCN U45014 · NHS Cheshire and Merseyside Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    49,082

    Registered population

    61.8% aged 18–64

    17.6%

    Aged 65+

    ICB 19.0% · England 17.9%

    7.8%

    Ethnic minority (non-White)

    4.1% Asian · England 9.6%

    15.1%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~5,922

    Core20 residents (est.)

    Resident basis; registered basis ~9,534 · see page 3

    7,262

    Hypertension register

    +5.89% in 3 yrs · England +5.60%

    524

    SMI register

    23.5% of Warrington (LAD)'s

    869

    COPD register

    Reviews +3.62% in 3 yrs

    Forecast to 2030

    8,455

    Hypertension patients, 2030

    +1,193 on today

    70.9%

    QRISK ≥20% on statins, 2030

    +4.49pp over 3 yrs

    3.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    61.6%
    Asthma annual reviews trail England benchmark.

    Annual review completion is 61.6% against 65.7% in England (1,185 unreviewed scale across 3,084 patients), which may reflect recall gaps to test by audit.

    -3.6 pp
    Three-year declines in severe mental illness checks.

    Mental health register BMI recording changed by -3.6 pp (England +5.1 pp) and blood pressure checks by -1.7 pp (England +4.4 pp) over 2023.

    70.1%
    Hypertension blood pressure control exceeds borough rate.

    Patients treated to blood pressure target reach 70.1% (Warrington (LAD) 68.7%, ICB 69.1%, England 70.3%), and 83.5% in those aged 80+ (England 81.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered list of 49,082 patients has 20.6% aged 0-17 and 17.6% aged 65+

    Warrington Innovation PCN has 49,082 registered patients. Patients aged 0-17 represent 20.6% (10,119), above Warrington (LAD) (19.7%), NHS Cheshire and Merseyside Integrated Care Board (19.2%), and England (19.6%). Those aged 65+ comprise 17.6% (8,632), against 17.5% in Warrington (LAD), 19.0% in NHS Cheshire and Merseyside Integrated Care Board, and 17.9% in England. Catchment Census data (resident, not registered) records 92.2% White and 4.1% Asian or Asian British (Warrington (LAD) 3.3%, NHS Cheshire and Merseyside Integrated Care Board 2.8%, England 9.6%), ranging from 7.0% at Springfields Medical Centre to 1.7% at Culcheth Medical Centre.

    Age profile

    0–1720.6%
    18–6461.8%
    65+17.6%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White92.2%
    Asian4.1%
    Mixed1.6%
    Other1.1%
    Black1.0%

    Older people · falls rows are Warrington (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Warrington LA)1,7372,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.3%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Warrington LA)9051,0219552024/25
    Falls deaths, all ages, per 100,000 (Warrington LA)12.118.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation averages decile 6.4 PCN-wide but spans a 72.7 percentage-point practice range

    Warrington Innovation PCN's Core20 share is 15.1%, below Warrington (LAD) (16.9%), NHS Cheshire and Merseyside Integrated Care Board (31.9%), and England (21.0%), with an average IMD decile of 6.4. Practice shares span 72.7 pp, yielding a 19.4% weighted share. Highest concentration sits at 4 Seasons Medical Centre (72.65%; 1,619 estimated patients), whereas highest volume is at Springfields Medical Centre (41.19%; 3,533 estimated patients). Denominators diverge between 9,534 registered practice estimates and 5,922 associated residents. Targeting must balance high-concentration outreach with high-volume clinical review capacity.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    4 Seasons72.7% · 1,619 patients
    Springfields41.2% · 3,533 patients
    Parkview34.3% · 1,702 patients
    Guardian Street21.8% · 2,680 patients
    Culcheth0.0% · 0 patients
    Chapelford0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    524

    SMI register

    1.08% recorded prevalence

    270

    Learning disability register

    0.56% recorded prevalence

    31

    Care homes, 1,250 beds

    In the PCN catchment

    9.4%

    Provide unpaid care

    Warrington (LAD), Census 2021

    Recorded registers include 524 patients with severe mental illness (1.1%) and 270 with learning disabilities (0.6%), compared with Warrington (LAD) (1.0% and 0.5%), NHS Cheshire and Merseyside Integrated Care Board (1.1% and 0.6%), and England (1.0% and 0.6%). The catchment area includes 31 care homes with 1,250 beds. Crude register prevalence and site bed capacity do not establish unmet need or resident patient occupancy.

    Severe mental illness: physical health checks

    Across 524 SMI patients, three-year monitoring fell while England rose: BMI recording dropped 3.6 pp (England +5.1 pp) and blood pressure checks fell 1.7 pp (England +4.4 pp). These declines could widen physical-health inequalities, which audits can test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,262

    Hypertension register

    +5.89%

    Register growth, 3 yrs

    Warrington (LAD) +6.41% · England +5.60%

    +1.73pp

    BP control, under 80

    ≤140/90 · +2.05pp aged 80+

    +1,193

    More patients by 2030

    Forecast 8,455 (16.74%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.9% across 7,262 registered patients, below Warrington (16.4%), NHS Cheshire and Merseyside ICB (16.8%) and England (15.2%). Practice prevalence ranges from 10.1% at Chapelford Primary Care Centre to 17.4% at Culcheth Medical Centre. An unadjusted benchmark model indicates an illustrative gap range of +213 to +791 patients against England and Warrington (LAD), though crude prevalence does not establish under-detection. For recorded patients, 89.2% have a recent blood pressure reading (Warrington 86.2%, England 90.0%) and 70.1% are treated to target, exceeding Warrington (68.7%) and ICB (69.1%) rates. Lower recorded prevalence alongside strong blood pressure control suggests case-finding audits could help identify undiagnosed hypertensive patients in lower-prevalence practices.

    Lipids and statins

    Lipid-lowering therapy uptake in QRISK ≥ 20% patients is 60.8% (England 63.6%). Statin therapy also trails England across diabetes without CVD (68.2% vs 73.2%), diabetes with CVD (79.9% vs 84.4%) and CKD (67.9% vs 70.3%). Fewer at-risk patients receive lipid-lowering therapy than England rates imply, highlighting a priority to audit high-risk treatment initiation.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202679,281£1.70£1.71£1.86£134,778
    Cardiovascular (all), 2025111,730£4.73£4.37£3.33£528,483

    In 2026, the PCN prescribed 79,281 lipid-modifying items (£134,778 spend) at £1.70 per item (England £1.86), spending £12,685 less than at England's unit cost. Lower unit costs than England mean average cost per item is below national benchmarks across 79,281 items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +0.44%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.19%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.7% across 3,084 patients, yet annual review completion is 61.6% (Warrington (LAD) 61.4%, England 65.7%), indicating an unreviewed scale of 1,185 patients. Over three years, asthma reviews changed by +0.4% (England +4.4%). Asthma prescribing for ages 5–19 is 1,285 per 1,000 (England 1,488). Recorded COPD prevalence is 1.8% (869 patients), with review completion at 67.8% trailing Warrington (LAD) (72.3%) and England (76.4%). Lower review rates could reflect recall barriers, which practice audits can evaluate.

    Cancer register and children's immunisation

    Cancer recorded prevalence is 3.4% (1,646 patients), below England (3.8%). In Q1 2025/26, MMR coverage at age 5 dropped 2.4 pp from 96.8% for dose 1 to 94.4% for dose 2, falling 0.6 pp below the 95.0% target across a cohort of 126 children. At 24 months, MMR1 and 6-in-1 coverage reached 91.4%. This dose gap could leave children incompletely protected before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.3%

    England 91.0%

    6-in-1 complete primary course at 24 months91.4%

    England 92.2%

    MMR dose 1 at 24 months91.4%

    England 88.3%

    MMR dose 2 at age 594.4%

    England 82.8%

    4-in-1 pre-school booster at age 594.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of cancers with a known stage (7,482 of 13,490; 72.8% staged) were diagnosed at stage 1 or 2, against 55.3% in England, below the 75.0% national ambition by 2028 and requiring about 2,640 extra early diagnoses annually. System stage metrics reflect wider geography, not PCN performance. In Warrington Innovation PCN, cervical screening coverage (aged 25–49) is 69.6% (England 66.8%), but three-year change fell 1.5% (England -1.0%), varying from 56.0% at 4 Seasons Medical Centre to 77.7% at Culcheth Medical Centre. Lagging screening uptake at lower-performing practices may hinder early detection across the local care pathway.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For North Cheshire and Mersey NHS Foundation Trust in provisional July 2026 data, 62-day cancer referral to treatment reached 83.7% (85.0% standard), above Mersey and West Lancashire Teaching Hospitals NHS Trust (78.0%), NHS Cheshire and Merseyside Integrated Care Board (76.2%), Manchester University NHS Foundation Trust (72.8%) and England (71.2%). The 28-day faster diagnosis standard was 80.2% (standard 75.0%). Diagnostic waits of 6+ weeks were 0.5% for MRI and 2.3% for CT, below Manchester University NHS Foundation Trust (11.7% and 14.7%) and England (21.4% and 9.9%). Provider data reflects hospital activity, not PCN performance.

    Pathways within standard (%)North Cheshire and MerseyMersey and West LancashireManchesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)80.2172.3980.0677.2579.32
    31-day treatment (96%)98.1795.4692.5495.7192.50
    62-day referral to treatment (85%)83.6777.9672.8576.2371.16
    Diagnostic waits over 6 weeks (%)North Cheshire and MerseyMersey and West LancashireManchesterEngland
    MRI0.5314.0411.6821.40
    CT2.3213.0814.669.92
    Echocardiography28.0434.884.9128.48
    Colonoscopy15.9818.044.5130.83
    Gastroscopy20.2418.1729.3529.02
    All 15 DM01 tests6.3421.178.9823.14
    Community services activityWarrington residentsCheshire and Merseyside ICB
    Care contacts38,550541,280
    Referrals7,32097,150
    Patients with a contact14,830146,240

    Community services (residents of Warrington), Jun 2026 (provisional). In provisional June 2026 community services data for Warrington residents, 56% of all recorded community contacts (21,595 of 38,550) were with adults aged 65 and over. These figures reflect borough resident activity across community service providers and are not captured at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 37.2 pp and overall good experience spans 28.4 pp

    In 2025/26, QOF overall achievement spans from 73.7% at 4 Seasons Medical Centre to 99.2% at Culcheth Medical Centre (England 92.5%). Vaccination and immunisation achievement shows a 76.4 pp spread, from 20.6% at Parkview Medical Centre to 97.0% at Culcheth Medical Centre (England 55.2%). Personalised care adjustment rates across all domains reach 15.3% at 4 Seasons Medical Centre (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Guardian Street12621.863.9%76.7%84.1%
    Springfields15041.268.5%75.0%84.1%
    Culcheth1200.053.8%71.3%80.9%
    Parkview11534.369.5%69.7%72.7%
    4 Seasons9872.742.8%48.4%58.6%
    Chapelford1030.032.4%58.5%55.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWarrington (LAD)AssetPCNWarrington (LAD)
    Care homes (catchment)31 (1,250 beds)n/aSchools (catchment)79n/a
    Children's centres612Places of worship5489
    Libraries47Primary schools (LA maintained)1628
    Primary academies1731Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension case-finding and register audit

    Recorded hypertension prevalence is 14.9% (7,262 patients on a 49,082 list) against 15.2% in England and 16.4% in Warrington (LAD), giving an unadjusted range of +213 to +791. For discussion: practices could run searches for repeated raised blood pressure readings without a diagnosis code and offer opportunistic checks. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured asthma annual review recall

    Asthma annual review completion is 61.6% across the 3,084-patient register against 65.7% in England (4.1 pp below England), indicating a scale of 1,185 unreviewed patients. For discussion: practices could standardise asthma recall templates, align inhaler prescribing checks with annual reviews, and test after-school or holiday slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    SMI physical health check consolidation

    On the 524-patient SMI register, three-year checks fell: BMI by 3.6 pp (England +5.1 pp), alcohol by 2.1 pp (England +5.4 pp), and BP by 1.7 pp (England +4.4 pp). For discussion: practices could audit partial-check coding, offer single-visit physical health checks, and raise shared-care reconciliation with system partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health check audit (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Access and triage workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension case-finding and register audit (p12)Hypertension register · Hypertension: QOF prevalence · Registered populationCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · SMI physical health check consolidation (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15